Ahmad Sadr
Corporate Officer/Principal at APELLIS PHARMACEUTICALS, INC.
Ahmad Sadr active positions
| Companies | Position | Start | End |
|---|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
| Chief Tech/Sci/R&D Officer | 2016-12-31 | - |
Career history of Ahmad Sadr
Former positions of Ahmad Sadr
| Companies | Position | Start | End |
|---|---|---|---|
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2016-04-30 | 2016-12-31 |
Vision Medicines, Inc.
 Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Chief Tech/Sci/R&D Officer | 2015-03-31 | 2016-04-30 |
Training of Ahmad Sadr
| University of Maryland | Undergraduate Degree |
| Widener University | Graduate Degree |
Statistics
International
| United States | 6 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Vision Medicines, Inc.
Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Ahmad Sadr
- Experience
